Company Overview and News

18
Graphite Miners News For The Month Of August 2018

2018-08-28 seekingalpha - 1
Graphite market news - "The graphite electrode market is expected to sustain its growth momentum in the current year (2018-19) as the demand-supply gap is expected to widen."
GRXXF URA SRHYY BKR BSSMF LMRMF URLNF URRE ZEYYF GPHEF RNU ABGPF GPHOF BSM LLG APMFD NSRC KBBRF CYLYF AMVMF WKT IMYSY FMS GRPH TON ZENYF DNI BKT MUS IMYSF DMNKF SYR GLKIF LMR NGPHF TLG ALP LEMIF GLK WWR ZEN FSRCY SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF CZSVF

24
Graphite Miners News For The Month Of July 2018

2018-07-28 seekingalpha - 4
Graphite spot prices were flat in July. AMR - "Graphite prices high – batteries and electrodes could push H2 2018 prices even higher."
GRXXF URA SRHYY BKR BSSMF LMRMF URLNF URRE ZEYYF GPHEF IAG RNU ABGPF GPHOF BSM LLG APMFD NSRC KBBRF CYLYF AMVMF WKT IMYSY FMS GRPH TON ZENYF DNI BKT MUS IMYSF DMNKF SYR GLKIF LMR NGPHF TLG ALP LEMIF GLK WWR ZEN FSRCY SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF CZSVF

11
Graphite Miners News For The Month Of June 2018

2018-06-28 seekingalpha - 1
Graphite market news - Graphite to stay dominant in lithium battery anodes. Natural flake graphite market expected to move into deficit around 2020.
GRXXF URA SRHYY BKR BSSMF LMRMF URLNF URRE ZEYYF GPHEF IAG RNU GPHOF BSM LLG APMFD NSRC KBBRF CYLYF AMVMF WKT IMYSY FMS GRPH TON ZENYF DNI BKT MUS IMYSF DMNKF SYR GLKIF LMR NGPHF TLG LEMIF GLK WWR ZEN FSRCY SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF CZSVF GNG

 
Talga in $8.5m raising

2018-06-28 businessnews.com.au
West Perth-based junior miner Talga Resources has announced an oversubscribed placement raising $8.5 million to fund growth of its graphite and graphene technologies business.
TLG

10
Graphite Miners News For The Month Of May 2018

2018-05-30 seekingalpha
Graphite company news - Battery Minerals raises A$20m for Montepuez. Triton Minerals signs second graphite offtake deal for Ancuabe.
GRXXF URA SRHYY BKR BSSMF LMRMF URLNF URRE ZEYYF GPHEF IAG RNU GPHOF BSM LLG APMFD NSRC KBBRF CYLYF AMVMF WKT IMYSY FMS GRPH TON ZENYF DNI BKT MUS IMYSF DMNKF SYR GLKIF LMR NGPHF TLG LEMIF GLK WWR ZEN FSRCY SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF CZSVF

 
Talga Resources test work shows superiority of its battery graphite anode material

2018-05-15 proactiveinvestors.com.au
Talga Resources Ltd (ASX:TLG) has received performance test work results for its graphite anode material in commercial-size cells for lithium-ion batteries.
TLG

21
Graphite Miners News For The Month Of April 2018

2018-04-29 seekingalpha - 2
Graphite company news - Syrah Resources officially opens their Balama Graphite operation in Mozambique. Triton Minerals signs first binding offtake deal with China’s Qingdao Tianshengda Graphite.
GRXXF URA SRHYY CNA IMYSY FMS MALRY TON LMRMF MIN URLNF ZENYF URRE DNI MUS IMYSF DMNKF SYR ZEYYF GLKIF IAG LMR RNU ABGPF NGPHF TLG LLG ALP LEMIF NSRC GLK KBBRF WWR ZEN CYLYF AMVMF SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF MALRF

9
Graphite Miners News For The Month Of March 2018

2018-03-31 seekingalpha - 4
Graphite spot and contract price news - graphite prices have begun to move up boosted by an improving steel industry, a China environmental crackdown, and a strong Li-ion battery demand.
SRHYY IMYSY FMS TON ZENYF IMYSF SYR ZEYYF GLKIF IAG TORVF ABGPF NGPHF TLG LLG ALP NSRC GLK KBBRF WWR ZEN CYLYF AMVMF SYAAF KNL NSRCF MGPHF FCSMF SJL

3
Talga Resources Ltd.: Low Cost Commercial Graphene Production With Cobalt Upside

2018-03-28 seekingalpha
Partnerships with companies such as Bosch, BASF, Heidelberg Cement and Tata motors to commercialise graphene enhanced products.
TLG JMPLY JMPLF 500570 TATAMOTORS TTM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:TLG / TALGA RESOURCES LTD on message board site Silicon Investor.

Tollgrade Communications.....Nasdaq- TLGD Tollgrade Communications.....Nasdaq- TLGD Tollgrade Communications.....Nasdaq- TLGD CTLG as a Backdoor Internet play! CTLG as a Backdoor Internet play! CTLG as a Backdoor Internet play!
Check out Specialty Catalog Corp (CTLG) Check out Specialty Catalog Corp (CTLG) Check out Specialty Catalog Corp (CTLG)